• Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Oncology
  • AI
  • Topics
    • Back to parent navigation item
    • Topics
    • Technology
    • Resources
    • Diseases
    • Drugs and therapies
    • Research and development
    • Tools and techniques
    • Business
  • Webinars
  • Reports
  • Home
  • News
  • Oncology
  • AI
  • Topics
      • Technology
      • Resources
      • Diseases
      • Drugs and therapies
      • Research and development
      • Tools and techniques
      • Business
    • Conference Hall
      AACR 2026 part two: integrating AI, spatial biology and next-gen therapeutics
    • AACR 2
      AACR 2026 part one: AI design, precision biology and the next wave of oncology innovation
    • 16_Still01_Bo and Lexi looking at computer_cleaned
      When scale meets insight: reinventing SPR for the future of drug discovery
  • Webinars
  • Reports
  • More navigation items

Premium members qualification

  • No comments

Topics

  • Neurological disorders
  • No comments

Related articles

  • shutterstock_2841889079
    Article

    Turning CNS biomarkers into better drug development decisions

    2026-09-17T07:00:00Z

    Contributor Dr Roland Bürli, Dr Francesca Capotosti and Dr Antonella Pirone, Drug Target Review

  • AdobeStock_976466856
    News

    Why researchers are targeting Nav1.7 in the search for longer-lasting pain relief

    2026-09-16T13:44:00Z

    Sam Wightwick

  • shutterstock_2670403777
    News

    Microproteins emerge as potential new Alzheimer’s targets

    2026-09-15T10:03:00Z

    Sam Wightwick

  • shutterstock_2518649331
    News

    Nasal spray delivers amniotic vesicles to combat Alzheimer’s disease

    2026-09-14T11:10:00Z

    Sam Wightwick

  • shutterstock_2579142625
    News

    Solute carrier transporters open new frontier in neurological drug discovery

    2026-09-11T10:47:00Z

    Sam Wightwick

  • shutterstock_2615909847
    News

    OutSee secures £50k innovate UK grant for AI target validation

    2026-09-08T13:14:00Z

    Sam Wightwick

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register

Partner content

  • shutterstock_2841889079
    Article

    Turning CNS biomarkers into better drug development decisions

    2026-09-17T07:00:00

    Contributor Dr Roland Bürli, Dr Francesca Capotosti and Dr Antonella Pirone, Drug Target Review

  • shutterstock_2288981587
    Article

    How AI and human biology data led to a new addiction drug candidate

    2026-07-21T09:36:00

    Contributor Jayson Uffens, Drug Target Review

  • BBB Image
    Article

    Why the blood–brain barrier blocks most drugs – and how ultrasound could help

    2026-07-31T06:00:00

    Contributor Dr Davinder Ramsingh, Drug Target Review

  • CELLVO~1
    Webinar

    What it takes to automate high-content imaging at scale

    2026-03-25T15:00:00

    Sponsored by Yokogawa

  • shutterstock_2771790713
    Article

    Women in STEM: resilience and leadership in rare disease research

    2026-05-19T09:46:00

    Contributor Dr Nitza Thomasson

  • Computer,Screen,With,Molecular,Modelling,Software,Simulating,Proteins,,Designing,New
    Webinar

    The truth about AI in drug discovery: what the experts really think

    2026-03-11T14:00:00

    Sponsored by Merck

  • Topics
  • Technology
  • Resources
  • Diseases
  • Drugs and therapies
  • Research and development
  • Tools and techniques
  • Business
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
The trusted voice in drug discovery
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 Drug Target Review

Site powered by Webvision Cloud